IOL Chemicals

When is the next results date for IOL Chemicals?

No Upcoming Board Meetings

What does IOL Chemicals do?

IOL Chemicals and Pharmaceuticals Ltd specializes in Active Pharmaceutical Ingredients (APIs) and specialty chemicals, with a market cap of Rs 2,609 Cr and reported net sales of 528 Cr and net profit of 31 Cr for Q1 2025. The company, established in 1986, operates in the Pharmaceuticals & Biotechnology industry.

Overview:<BR>IOL Chemicals and Pharmaceuticals Ltd is a prominent player in the Active Pharmaceutical Ingredient (API) and specialty chemicals sectors, operating within the Pharmaceuticals & Biotechnology industry and categorized as a Small Cap company.<BR><BR>History:<BR>Incorporated in September 1986, IOL Chemicals has established itself in the pharmaceutical sector. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 528 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 31 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 2,609 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 25.00<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.91%<BR>- Debt Equity: -0.06<BR>- Return on Equity: 5.99%<BR>- Price to Book: 1.51<BR><BR>Contact Details:<BR>Address: Trident Complex, Raikot Road Barnala Sangrur Punjab : 148101<BR>Tel: 91-01679-244701-07<BR>Email: contact@iolcp.com<BR>Website: http://www.iolcp.com

Who are in the management team of IOL Chemicals?

As of March 2023, the management team of IOL Chemicals includes Varinder Gupta (Managing Director), Vikas Gupta (Joint Managing Director), Kushal Kumar Rana (Director), Abhiraj Gupta (Executive Director), and Abhay Raj Singh (Company Secretary). The board also features independent directors such as Rajender Mohan Malla (Chairman), Sandhya Mehta, Harpal Singh, and Sharad Tyagi.

As of March 2023, the management team of IOL Chemicals includes the following individuals:<BR><BR>1. Varinder Gupta - Managing Director<BR>2. Vikas Gupta - Joint Managing Director<BR>3. Kushal Kumar Rana - Director (Works)<BR>4. Abhiraj Gupta - Executive Director<BR>5. Abhay Raj Singh - Company Secretary & Compliance Officer<BR><BR>Additionally, the board features several independent and non-executive directors, including:<BR>- Sandhya Mehta - Non-Executive & Independent Director<BR>- Rajender Mohan Malla - Chairman & Independent Director<BR>- Harpal Singh - Non-Executive & Independent Director<BR>- Sharad Tyagi - Independent Director<BR><BR>This team is responsible for the strategic direction and governance of the company.

Who are the peers of the IOL Chemicals?

IOL Chemicals' peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, Novartis India, Indoco Remedies, Senores Pharma, SMS Pharma, and Syncom Formul. While IOL Chemicals has average management risk and a 1-year return of 23.27%, its growth is below average compared to its peers.

Peers: The peers of IOL Chemicals are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Novartis India, Indoco Remedies, Senores Pharma., SMS Pharma, and Syncom Formul.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Torrent Pharma, Dr Reddy's Labs, and the rest. Average management risk is found at IOL Chemicals, Novartis India, Indoco Remedies, SMS Pharma, and the rest. Below Average management risk is noted for Senores Pharma. Growth is excellent for Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and the rest, while IOL Chemicals, Divi's Lab., Indoco Remedies, Torrent Pharma, SMS Pharma, and the rest show below average growth. Good growth is seen at Novartis India, and Senores Pharma. has excellent growth. Capital structure is excellent for Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, IOL Chemicals, Novartis India, and the rest, while average capital structure is found at Indoco Remedies and SMS Pharma.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while Novartis India has the lowest at -3.58%. IOL Chemicals has a 1-year return of 23.27%, which is higher than Novartis India but lower than Divi's Lab. Additionally, Indoco Remedies and SMS Pharma have negative six-month returns.

Is IOL Chemicals overvalued or undervalued?

As of May 19, 2025, IOL Chemicals is considered very expensive and overvalued compared to its peers, with key financial ratios significantly higher and lower returns, making it an unfavorable investment despite a recent strong performance.

As of 19 May 2025, the valuation grade for IOL Chemicals has moved from fair to very expensive. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of 25.73, an EV to EBITDA of 12.39, and a Price to Book Value of 1.54, which are significantly higher than many of its peers.<BR><BR>In comparison, Solar Industries has a PE ratio of 123.77 and an EV to EBITDA of 76.22, while Godrej Industries, which is rated attractive, has a PE ratio of 46.63 and an EV to EBITDA of 34.36. These comparisons highlight that IOL Chemicals is not only overvalued relative to its peers but also lacks competitive returns, with a ROE of 5.99% and a ROCE of 8.18%. Despite a strong 1-month return of 42.94% compared to the Sensex's 3.88%, the overall valuation indicates that IOL Chemicals is not a favorable investment at this time.

Who are the top shareholders of the IOL Chemicals?

The top shareholders of IOL Chemicals include Maya Devi Polycot Limited with 21.54%, Vasudeva Commercials Limited at 7.94%, and individual investors holding 31.43%. Mutual funds hold 0.02%, while Foreign Institutional Investors (FIIs) account for 1.47%.

The top shareholders of IOL Chemicals include the promoters, who hold a significant majority. The promoter with the highest holding is Maya Devi Polycot Limited, which owns 21.54% of the shares. Additionally, the highest public shareholder is Vasudeva Commercials Limited, holding 7.94%. Individual investors collectively hold 31.43% of the shares, while mutual funds have a minor stake through six schemes, accounting for 0.02%. Foreign Institutional Investors (FIIs) hold 1.47% of the company through 47 different entities.

How big is IOL Chemicals?

As of 24th July, IOL Chemicals & Pharmaceuticals Ltd has a market capitalization of 2,894.00 Cr, with recent net sales of 2,079.21 Cr and a net profit of 101.07 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: IOL Chemicals & Pharmaceuticals Ltd has a market capitalization of 2,894.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 2,079.21 Cr, while the sum of Net Profit for the same period is 101.07 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2024. Shareholder's Funds are valued at 1,611.51 Cr, and Total Assets amount to 2,244.40 Cr.

Is IOL Chemicals technically bullish or bearish?

As of October 9, 2025, IOL Chemicals exhibits a mildly bullish trend supported by MACD and Bollinger Bands, though tempered by a mildly bearish KST and Dow Theory signals on the weekly chart.

As of 9 October 2025, the technical trend for IOL Chemicals has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by weekly and monthly MACD indicators both showing bullish signals. The Bollinger Bands also reflect a mildly bullish trend in both time frames. However, the KST indicates a mildly bearish stance on the weekly chart, and Dow Theory shows a mildly bearish trend on the weekly level with no trend on the monthly. The daily moving averages are mildly bullish, but the overall strength is tempered by the recent price action, including a decline from the previous close.

Are IOL Chemicals latest results good or bad?

IOL Chemicals' latest results show strong year-on-year growth, with a 56.50% increase in net profit and record revenue of ₹567.53 crores. However, there are concerns due to an 11.67% decline in net profit from the previous quarter and contracting operating margins, indicating potential challenges ahead.

IOL Chemicals' latest results present a mixed picture. On one hand, the company achieved a significant year-on-year increase in net profit, which surged by 56.50% to ₹29.97 crores compared to the same quarter last year. Additionally, revenue reached an all-time high of ₹567.53 crores, reflecting a 7.95% increase year-on-year and a 2.87% growth quarter-on-quarter.<BR><BR>However, the sequential performance raises concerns. The net profit declined by 11.67% from the previous quarter, which indicates potential challenges in maintaining profitability. Operating margins also contracted, falling from 11.26% in the previous quarter to 10.06%, suggesting pressure on margins despite the revenue growth.<BR><BR>Overall, while the year-on-year results are strong and indicate operational improvements, the sequential decline in profit and margins points to underlying issues that could affect sustainability. Investors should keep an eye on these trends to assess the company's future performance.

How has been the historical performance of IOL Chemicals?

IOL Chemicals has experienced a declining trend in net sales and profits over the past few years, with net sales dropping from 2,217.11 Cr in March 2023 to 2,079.21 Cr in March 2025, and profit after tax decreasing from 134.43 Cr to 101.07 Cr in the same period. Despite this, total assets increased to 2,382.07 Cr in March 2025.

Answer:<BR>The historical performance of IOL Chemicals shows a declining trend in net sales and profits over the past few years.<BR><BR>Breakdown:<BR>IOL Chemicals reported net sales of 2,079.21 Cr in March 2025, down from 2,132.79 Cr in March 2024 and 2,217.11 Cr in March 2023, indicating a consistent decrease in revenue. Total operating income mirrored this decline, with figures of 2,079.21 Cr in March 2025 compared to 2,132.79 Cr in the previous year. The total expenditure, excluding depreciation, also decreased to 1,876.91 Cr in March 2025 from 1,902.20 Cr in March 2024. Operating profit (PBDIT) fell to 224.71 Cr in March 2025, down from 260.66 Cr in March 2024, while profit before tax decreased to 137.96 Cr from 181.65 Cr. Consequently, profit after tax was 101.07 Cr in March 2025, a decline from 134.43 Cr in March 2024. The company's total assets increased to 2,382.07 Cr in March 2025 from 2,244.40 Cr in March 2024, while total liabilities also rose to 2,382.07 Cr from 2,244.40 Cr. Cash flow from operating activities was 178.00 Cr in March 2025, down from 289.00 Cr in March 2024, but net cash inflow improved to 70.00 Cr from 6.00 Cr. Overall, the financial metrics reflect a challenging period for IOL Chemicals, characterized by declining sales and profits despite an increase in total assets.

Should I buy, sell or hold IOL Chemicals & Pharmaceuticals Ltd?

Has IOL Chemicals & Pharmaceuticals Ltd declared dividend?

Yes, IOL Chemicals & Pharmaceuticals Ltd has declared a 50% dividend, amounting to ₹4 per share, with an ex-date of February 18, 2025. Despite recent volatility, the company has shown positive total returns over the 1-year (8.15%) and 3-year (35.53%) periods.

IOL Chemicals & Pharmaceuticals Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 50%<BR>- Amount per share: 4<BR>- Ex-date: Feb-18-2025<BR><BR>Dividend Yield: 1.05%.<BR><BR>Total Returns by Period:<BR>In the last 3 months, the price return was -23.6%, the dividend return was 1.05%, resulting in a total return of -22.55%.<BR><BR>Over the past 6 months, the price return was -20.07%, the dividend return was 1.06%, leading to a total return of -19.01%.<BR><BR>In the 1-year period, the price return was 6.64%, the dividend return was 1.51%, culminating in a total return of 8.15%.<BR><BR>For the 2-year period, the price return was -6.18%, the dividend return was 6.07%, resulting in a total return of -0.11%.<BR><BR>In the last 3 years, the price return was 18.32%, the dividend return was 17.21%, which led to a total return of 35.53%.<BR><BR>Over the 4-year period, the price return was -7.45%, the dividend return was 21.63%, resulting in a total return of 14.18%.<BR><BR>In the 5-year span, the price return was -44.32%, the dividend return was 16.35%, leading to a total return of -27.97%.<BR><BR>Overall, IOL Chemicals & Pharmaceuticals Ltd has declared a substantial dividend, and while the recent total returns have shown volatility, the company has managed to provide positive returns over longer periods, particularly in the 1-year and 3-year spans.

Why is IOL Chemicals & Pharmaceuticals Ltd falling/rising?

As of 23-Mar, IOL Chemicals & Pharmaceuticals Ltd is facing a stock price decline to Rs 71.60, influenced by sector-wide downturns, reduced investor interest, and poor long-term growth metrics. Despite recent outperformance against the Sensex, concerns over high valuations and low mutual fund participation contribute to the stock's negative outlook.

As of 23-Mar, IOL Chemicals & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 71.60, which reflects a change of -2.66 (-3.58%). This downward movement can be attributed to several factors highlighted in the source data. <BR><BR>Firstly, the stock has shown a negative performance today, with an intraday low of Rs 71.2, indicating a drop of 4.12%. The overall sector, Chemicals, has also fallen by 3.81%, which suggests that the decline is part of a broader trend affecting the industry. Additionally, there has been a significant decrease in investor participation, with delivery volume dropping by 43.55% compared to the 5-day average, indicating reduced interest from investors.<BR><BR>Moreover, while the stock has outperformed the benchmark Sensex over the past week with a return of +4.54%, its longer-term performance reveals concerns. The stock has declined by 12.95% year-to-date and 1.96% over the past month, which raises questions about its sustainability. Despite a positive PAT growth of 33.32% and record net sales in the last quarter, the company has shown poor long-term growth, with net sales growing at only 0.38% annually over the last five years.<BR><BR>The stock's valuation also appears to be a concern, trading at a premium compared to its peers, with a Price to Book Value of 1.2. This, combined with a low return on equity (ROE) of 6.6, suggests that investors may be wary of the stock's long-term prospects. Furthermore, the minimal stake held by domestic mutual funds, at only 0.04%, indicates a lack of confidence in the stock's current valuation.<BR><BR>In summary, the combination of sector-wide declines, reduced investor participation, poor long-term growth metrics, and high valuations relative to peers are contributing to the falling stock price of IOL Chemicals & Pharmaceuticals Ltd.

Why is IOL Chemicals & Pharmaceuticals Ltd falling/rising?

As of 24-Mar, IOL Chemicals & Pharmaceuticals Ltd's stock price has risen to Rs 77.40, up 8.1%, driven by strong short-term performance and positive financial results, despite concerns about long-term growth potential. The stock has outperformed the sector today and shown significant gains over the past week and month.

As of 24-Mar, IOL Chemicals & Pharmaceuticals Ltd is experiencing a rise in its stock price, currently at Rs 77.40, reflecting an increase of Rs 5.8 or 8.1%. This upward movement can be attributed to several factors. Firstly, the stock has outperformed the sector by 5.71% today, indicating strong relative performance. Additionally, the stock reached an intraday high of Rs 79.18, which represents a 10.59% increase, showcasing positive investor sentiment.<BR><BR>In the context of recent performance, the stock has shown significant gains over the past week, with a rise of 13.47%, while the benchmark Sensex has declined by 2.63%. Over the past month, the stock has also increased by 7.60%, contrasting with a 9.92% drop in the Sensex. Furthermore, the company's financial results have been positive, with a 48.50% growth in profit after tax over the last six months and record net sales of Rs 580.39 crore.<BR><BR>However, it is important to note that despite these positive indicators, there are concerns regarding the company's long-term growth potential, as net sales have only grown at an annual rate of 0.38% over the last five years. Additionally, the stock is trading at a premium compared to its peers, which may affect investor confidence in the long run. Nonetheless, the current rise in stock price is primarily driven by strong short-term performance and positive financial results.

Why is IOL Chemicals & Pharmaceuticals Ltd falling/rising?

As of 25-Mar, IOL Chemicals & Pharmaceuticals Ltd's stock price has risen to Rs 78.80, reflecting a 2.14% increase due to strong recent performance, increased investor interest, and solid financial results, including a 48.50% growth in profit after tax. The stock has outperformed its sector and delivered a 22.74% return over the past year.

As of 25-Mar, IOL Chemicals & Pharmaceuticals Ltd is experiencing a rise in its stock price, currently at Rs 78.80, which reflects an increase of Rs 1.65 or 2.14%. This upward movement can be attributed to several factors. <BR><BR>Firstly, the stock has shown strong performance over the past two days, gaining a total of 10.06% during this period. Additionally, it has outperformed its sector by 0.44% today. The stock reached an intraday high of Rs 79.62, indicating positive investor sentiment. <BR><BR>Moreover, there has been a notable increase in investor participation, with delivery volume rising by 19.6% compared to the five-day average, suggesting heightened interest in the stock. The company's recent financial results also support this positive trend, as it reported a significant growth in profit after tax (PAT) of 48.50% over the last six months and achieved its highest net sales for a quarter at Rs 580.39 crore.<BR><BR>Despite some concerns regarding long-term growth and valuation, the stock has managed to deliver a remarkable return of 22.74% over the past year, significantly outperforming the broader market, which has seen negative returns. This combination of strong recent performance, increased investor interest, and solid financial results contributes to the current rise in the stock price of IOL Chemicals & Pharmaceuticals Ltd.

Which are the latest news on IOL Chemicals?